Among the three biomarkers, ALCAM exhibited superior diagnostic capability, with an AUC exceeding 0.8 in both Korean patients with SLE and LN, consistent with existing research findings (15–17). This evidence concerns the gene ALCAM and systemic lupus erythematosus.